INMUNOENSAYO PARA LA DETECCIÓN DE ANTICUERPOS DIRIGIDOS CONTRA EL VIRUS DEL ZIKA - COFEPRIS Registration 1613R2022 SSA

Access comprehensive regulatory information for INMUNOENSAYO PARA LA DETECCIÓN DE ANTICUERPOS DIRIGIDOS CONTRA EL VIRUS DEL ZIKA (INMUNOENSAYO PARA LA DETECCIÓN DE ANTICUERPOS DIRIGIDOS CONTRA EL VIRUS DEL ZIKA) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1613R2022 SSA and manufactured by KABLA COMERCIAL, S.A. DE C.V.. The device was registered on December 15, 2022.

This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.